1. Home
  2. CEE vs LNSR Comparison

CEE vs LNSR Comparison

Compare CEE & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CEE
  • LNSR
  • Stock Information
  • Founded
  • CEE 1990
  • LNSR 2004
  • Country
  • CEE Germany
  • LNSR United States
  • Employees
  • CEE N/A
  • LNSR N/A
  • Industry
  • CEE Finance Companies
  • LNSR Medical Electronics
  • Sector
  • CEE Finance
  • LNSR Health Care
  • Exchange
  • CEE Nasdaq
  • LNSR Nasdaq
  • Market Cap
  • CEE 72.9M
  • LNSR 63.4M
  • IPO Year
  • CEE N/A
  • LNSR N/A
  • Fundamental
  • Price
  • CEE $12.50
  • LNSR $8.25
  • Analyst Decision
  • CEE
  • LNSR
  • Analyst Count
  • CEE 0
  • LNSR 0
  • Target Price
  • CEE N/A
  • LNSR N/A
  • AVG Volume (30 Days)
  • CEE 22.0K
  • LNSR 52.9K
  • Earning Date
  • CEE 01-01-0001
  • LNSR 03-03-2025
  • Dividend Yield
  • CEE 3.86%
  • LNSR N/A
  • EPS Growth
  • CEE N/A
  • LNSR N/A
  • EPS
  • CEE N/A
  • LNSR N/A
  • Revenue
  • CEE N/A
  • LNSR $48,868,000.00
  • Revenue This Year
  • CEE N/A
  • LNSR $25.07
  • Revenue Next Year
  • CEE N/A
  • LNSR $24.95
  • P/E Ratio
  • CEE N/A
  • LNSR N/A
  • Revenue Growth
  • CEE N/A
  • LNSR 21.29
  • 52 Week Low
  • CEE $7.80
  • LNSR $2.67
  • 52 Week High
  • CEE $10.32
  • LNSR $9.23
  • Technical
  • Relative Strength Index (RSI)
  • CEE 62.53
  • LNSR 51.28
  • Support Level
  • CEE $11.65
  • LNSR $8.08
  • Resistance Level
  • CEE $12.32
  • LNSR $8.72
  • Average True Range (ATR)
  • CEE 0.36
  • LNSR 0.59
  • MACD
  • CEE 0.11
  • LNSR -0.08
  • Stochastic Oscillator
  • CEE 92.97
  • LNSR 48.68

About CEE The Central and Eastern Europe Fund Inc. (The)

CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.

About LNSR LENSAR Inc.

LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.

Share on Social Networks: